151
Participants
Start Date
September 30, 2013
Primary Completion Date
July 31, 2014
Study Completion Date
September 30, 2015
Insertable Cardiac Monitor Implant
The Reveal LINQ is a leadless device that is recommended to be implanted in the region of the thorax. Two electrodes on the body of the device continuously monitor the patient's subcutaneous ECG. The device stores ECG recordings from the patient-activated episodes and ECG recordings from automatically detected arrhythmias. Documentation of episode occurrence will be retained.
Royal Melbourne Hospital, Melbourne
The Prince Charles Hospital, Brisbane
Royal Adelaide Hospital, Adelaide
Allgemein öffentliches Krankenhaus der Elisabethinen Linz, Linz
Allgemeines Krankenhaus der Stadt Linz, Linz
UZ Leuven - Campus Gasthuisberg, Leuven
CHU UCL Mont-Godinne - Dinant, Yvoir
Catharina Ziekenhuis, Eindhoven
Academisch Ziekenhuis Maastricht, Maastricht
St. Antonius Ziekenhuis - Locatie Nieuwegein, Nieuwegein
Diakonessenhuis Locatie Utrecht, Utrecht
Isala Klinieken - Locatie Weezenlanden, Zwolle
Scientific Research Institute of Circulation's Pathology Agency on High Medical Technologies, Novosibirsk
Narodny ustav srdcovych a cievnych chorob, a.s. (NUSCH), Bratislava
Eastbourne District General Hospital, Eastbourne
James Cook University Hospital, Middlesbrough
Medtronic Cardiac Rhythm and Heart Failure
INDUSTRY